ATE520660T1 - Kristalline formen einer dimethylphenylverbindung - Google Patents

Kristalline formen einer dimethylphenylverbindung

Info

Publication number
ATE520660T1
ATE520660T1 AT07794375T AT07794375T ATE520660T1 AT E520660 T1 ATE520660 T1 AT E520660T1 AT 07794375 T AT07794375 T AT 07794375T AT 07794375 T AT07794375 T AT 07794375T AT E520660 T1 ATE520660 T1 AT E520660T1
Authority
AT
Austria
Prior art keywords
crystalline forms
dimethylphenyl compound
dimethylphenyl
compound
crystalline
Prior art date
Application number
AT07794375T
Other languages
English (en)
Inventor
Jennifer Bolton
Robert Chao
Miroslav Rapta
Lisa Williams
Richard D Wilson
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Application granted granted Critical
Publication of ATE520660T1 publication Critical patent/ATE520660T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT07794375T 2006-04-25 2007-04-24 Kristalline formen einer dimethylphenylverbindung ATE520660T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79470906P 2006-04-25 2006-04-25
PCT/US2007/010120 WO2007127297A2 (en) 2006-04-25 2007-04-24 Crystalline forms of a dimethylphenyl compound

Publications (1)

Publication Number Publication Date
ATE520660T1 true ATE520660T1 (de) 2011-09-15

Family

ID=38556280

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07794375T ATE520660T1 (de) 2006-04-25 2007-04-24 Kristalline formen einer dimethylphenylverbindung

Country Status (10)

Country Link
US (2) US7880010B2 (de)
EP (1) EP2010490B1 (de)
JP (1) JP2009535340A (de)
CN (1) CN101426765A (de)
AR (1) AR060648A1 (de)
AT (1) ATE520660T1 (de)
CA (1) CA2650631A1 (de)
PE (1) PE20080195A1 (de)
TW (1) TW200811104A (de)
WO (1) WO2007127297A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693202B1 (en) * 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
PE20040950A1 (es) * 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
USRE45404E1 (en) 2003-03-27 2015-03-03 Shin Nippon Biomedical Laboratories, Ltd. Powder medicine applicator for nasal cavity
US8673360B2 (en) * 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
EP1778626A1 (de) * 2004-08-16 2007-05-02 Theravance, Inc. Zusammensetzungen mit beta2-adrenergen-rezeptoragonist- und muskarinrezeptorantagonist-aktivität
TW200811105A (en) * 2006-04-25 2008-03-01 Theravance Inc Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
US20080071141A1 (en) * 2006-09-18 2008-03-20 Abhisuek Gattani Method and apparatus for measuring attributes of an anatomical feature during a medical procedure
CN101668544B (zh) 2006-12-26 2013-04-24 株式会社新日本科学 经鼻投用制剂
US20090216010A1 (en) * 2008-02-22 2009-08-27 Wei-Hong Tseng Crystalline carbapenem compound and produced method thereof
EP2419409B1 (de) * 2009-04-14 2015-01-28 Glaxo Group Limited Verfahren zur herstellung eines biphenyl-2-ylcarbaminsäureesters
RU2676686C2 (ru) 2009-04-23 2019-01-10 Тереванс Рэспирэйтори Кампани Эл Эл Си ДИАМИДНЫЕ СОЕДИНЕНИЯ, ОБЛАДАЮЩИЕ АКТИВНОСТЬЮ АНТАГОНИСТА МУСКАРИНОВОГО РЕЦЕПТОРА И АКТИВНОСТЬЮ АГОНИСТА β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
JP2012526726A (ja) * 2009-05-15 2012-11-01 株式会社新日本科学 薬物動態が改善された鼻腔内用薬学的組成物
WO2011013003A2 (en) 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
WO2011081937A1 (en) 2009-12-15 2011-07-07 Gilead Sciences, Inc. Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
EP2386555A1 (de) 2010-05-13 2011-11-16 Almirall, S.A. Neue Cyclohexylaminderivate mit Aktivitäten von Beta2-adrenergem Agonisten und M3-Muskarin-Antagonisten
AR083115A1 (es) 2010-09-30 2013-01-30 Theravance Inc Sales oxalato cristalinas de un compuesto diamida
EP2592077A1 (de) 2011-11-11 2013-05-15 Almirall, S.A. Neue Cyclohexylaminderivate mit Aktivitäten von Beta2-adrenergem Agonisten und M3-Muskarin-Antagonisten
EP2592078A1 (de) 2011-11-11 2013-05-15 Almirall, S.A. Neue Cyclohexylaminderivate mit Aktivitäten von Beta2-adrenergem Agonisten und M3-Muskarin-Antagonisten
WO2014175234A1 (ja) * 2013-04-26 2014-10-30 富士フイルム株式会社 撮像装置及び画像表示方法
CN107108502A (zh) * 2015-05-14 2017-08-29 四川海思科制药有限公司 具有β2受体激动及M受体拮抗活性的联苯衍生物及其在医药上的用途
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006635A1 (en) 1993-09-02 1995-03-09 Yamanouchi Pharmaceutical Co., Ltd. Carbamate derivative and medicine containing the same
EP0747355A4 (de) 1994-02-10 1997-04-09 Yamanouchi Pharma Co Ltd Neue carbamate und diese enthaltende arzneimittel
US6040344A (en) * 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
US6693202B1 (en) * 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
UA73965C2 (en) * 1999-12-08 2005-10-17 Theravance Inc b2 ADRENERGIC RECEPTOR ANTAGONISTS
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
TWI249515B (en) * 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
WO2003042160A1 (en) * 2001-11-13 2003-05-22 Theravance, Inc. Aryl aniline beta-2 adrenergic receptor agonists
PE20040950A1 (es) * 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
EP1622875B1 (de) * 2003-05-08 2009-12-02 Theravance, Inc. Kristalline formen eines arylanilin-beta-2-adrenergenrezeptor-agonists
JP4851937B2 (ja) * 2003-11-21 2012-01-11 セラヴァンス， インコーポレーテッド β２アドレナリン作動性受容体作動薬活性およびムスカリン受容体拮抗薬活性を有する化合物
EP1833822A2 (de) * 2004-08-16 2007-09-19 Theravance, Inc. Verbindungen mit beta2 adrenerg-rezeptor agonistischer und muscarin-rezeptor antagonistischer aktivität
TWI374883B (en) * 2004-08-16 2012-10-21 Theravance Inc Crystalline form of a biphenyl compound
EP1778626A1 (de) * 2004-08-16 2007-05-02 Theravance, Inc. Zusammensetzungen mit beta2-adrenergen-rezeptoragonist- und muskarinrezeptorantagonist-aktivität
US7558576B2 (en) * 2005-03-29 2009-07-07 Qualcomm Incorporated Employing frequency offset to compensate for Doppler shift
TW200811105A (en) * 2006-04-25 2008-03-01 Theravance Inc Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity

Also Published As

Publication number Publication date
JP2009535340A (ja) 2009-10-01
PE20080195A1 (es) 2008-04-04
TW200811104A (en) 2008-03-01
CN101426765A (zh) 2009-05-06
US7880010B2 (en) 2011-02-01
AR060648A1 (es) 2008-07-02
WO2007127297A3 (en) 2007-12-21
EP2010490B1 (de) 2011-08-17
US20070249674A1 (en) 2007-10-25
CA2650631A1 (en) 2007-11-08
WO2007127297A2 (en) 2007-11-08
EP2010490A2 (de) 2009-01-07
US20110086881A1 (en) 2011-04-14

Similar Documents

Publication Publication Date Title
ATE520660T1 (de) Kristalline formen einer dimethylphenylverbindung
ATE449762T1 (de) Kristalline formen einer biphenylverbindung
LTPA2020501I1 (lt) Pakeistieji enaminokarbonilo junginiai
ATE491700T1 (de) KRISTALLINE FORMEN VON 1-CHLORO-4-(ß-D-
DK2331538T3 (da) Krystallinske former af en 2-thiazolyl-4-quinolinyl-oxy-derivat, en potent HCV-inhibitor
ATE479682T1 (de) Kristalline form einer chinolin-carboxamid- verbindung
EP2123654A4 (de) Pyrazolopyrimidinverbindung
EP2055698A4 (de) Chromenverbindung
EP1985620A4 (de) 10a-AZALIDVERBINDUNG
EP2036901A4 (de) C-phenyl-1-thioglucitverbindung
DE502007001078D1 (de) Druckwerke einer druckmaschine
DE602007003618D1 (de) Anzieh-Werkzeug
BRPI0814801A2 (pt) composto de piridazina cristalina
IL197825A0 (en) Crystalline forms of a thizolidinedione compound and manufacturing methods thereof
BRPI0720097A2 (pt) Compostos de fosfonato
EP2373326A4 (de) Kristalline formen von genistein
DE602007012974D1 (de) Mechanismus zur Hilfe bei der Bedienung einer Kupplung
EP2213669A4 (de) Kristallines imidazol-5-carbonsäurederivat
PT2722046T (pt) Forma cristalina 1 de 2-((r)-2-metilpirrolidina-2-yl)-1hbenzimidazol- 4-carboxamida
EP2124549A4 (de) Antihypercholesterinämische verbindungen
EP2052178A4 (de) Bajonettverbindung
DE602006020758D1 (de) Längslenker einer aufhängung
ZA201104319B (en) Crystalline forms of a 3-carboxypropyl-aminotetralin compound
DK2154123T3 (da) Fremgangsmåde til fremstilling af en benzaldehydforbindelse
EP2036385A4 (de) Herstellen einer paketvermittelten peer-to-peer-verbindung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties